The US FTC and the Colorado Attorney General file a complaint against a merger between an insurance company and a health services business for resulting in both horizontal and vertical competitive effects (UnitedHealth / DaVita)

This article has been nominated for the 2020 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards.

On June 19, UnitedHealth Group Incorporated (UnitedHealth Group) and DaVita, Inc. (DaVita) agreed to two separate consent agreements to resolve antitrust concerns about UnitedHealth Group’s $4.3 billion acquisition of DaVita’s DaVita Medical Group (DMG) (the Acquisition). Both the Federal Trade Commission (FTC) and the Colorado Attorney General (Colorado AG) filed complaints alleging that the Acquisition would harm competition. Both complaints alleged concerns related to managed care provider organizations that provide physician and other health care services (MCPOs) and Medicare Advantage (MA). UnitedHealth Group operates two wholly owned subsidiaries relevant to the Acquisition: UnitedHealthcare, which sells MA and other insurance plans; and Optum, a health services business that

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • Axinn Veltrop & Harkrider (Washington)
  • Axinn Veltrop & Harkrider (Washington)

Quotation

Adam Cella, Jeny M. Maier, The US FTC and the Colorado Attorney General file a complaint against a merger between an insurance company and a health services business for resulting in both horizontal and vertical competitive effects (UnitedHealth / DaVita), 19 June 2019, e-Competitions June 2019, Art. N° 96867

Visites 30

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues